Literature DB >> 22311620

Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.

Heidi Lewis1, James Lewis.   

Abstract

Stimulant medications used as first-line treatment in attention deficit hyperactivity disorder (ADHD) are contraindicated in patients with glaucoma. We present the first reported case of using methylphenidate therapy to safely and effectively treat ADHD in a pediatric patient with glaucoma.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22311620     DOI： 10.1007/s12402-012-0071-9

Source DB:  PubMed          Journal:  Atten Defic Hyperact Disord        ISSN： 1866-6116


  2 in total

1.  Assessment of the lamina cribrosa in attention-deficit hyperactivity disorder.

Authors:  Serkan Akkaya; Döndü M Ulusoy; Hatice Doğan; Mahmut E Arslan
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

Review 2.  Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Authors:  Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Lærke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.